SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-099210
Filing Date
2021-08-03
Accepted
2021-08-03 09:27:03
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 tm2123538-1_s3.htm S-3 651713
2 EXHIBIT 1.2 tm2123538d2_ex1-2.htm EX-1.2 220988
3 EXHIBIT 4.3 tm2123538d2_ex4-3.htm EX-4.3 317982
4 EXHIBIT 4.4 tm2123538d2_ex4-4.htm EX-4.4 318656
5 EXHIBIT 5.1 tm2123538d2_ex5-1.htm EX-5.1 18209
6 EXHIBIT 5.2 tm2123538d2_ex5-2.htm EX-5.2 9521
7 EXHIBIT 23.1 tm2123538d2_ex23-1.htm EX-23.1 2951
8 GRAPHIC lg_esperion-4c.jpg GRAPHIC 66088
  Complete submission text file 0001104659-21-099210.txt   1632249
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258396 | Film No.: 211138245
SIC: 2834 Pharmaceutical Preparations